# Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

> **NCT06344767** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 19 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06344767
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-05-05
- **Final completion:** 2024-05-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344767, "Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06344767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*